AKCİĞER TÜBERKÜLOZLU KADIN VE ERKEK OLGULARIN KARŞILAŞTIRILMASI
Bu çalışma tüberkülozlu olgularda bakteriyolojik, radyolojik, klinik özellikler, laboratuvar bulguları, ilaç direnç oranları, tedaviye yanıt ve yan etkiler yönünden kadın ve erkekler arasında fark olup olmadığını araştırmak amacıyla planlandı. Kliniğimizde 4 yıllık period içerisinde bu tanı ile yatan olguların retrospektif olarak dosya kayıtları incelenerek ilk 100 kadın (yaş ort. 48.9) ve 100 erkek olgu (yaş ort. 47.3.) çalışmaya alındı. Her iki grupta en sık rastlanan semptom öksürük olup, balgam çıkarma dışında, semptomlar açısından gruplar arasında anlamlı farklılık saptanmadı. Semptomların başlama süresi kadınlarda daha yüksek bulundu (p=0.552). Kadınlarda tüberkülozlu ile temas (p=0.014), erkeklerde alkol ve sigara alışkanlığı belirgin olarak daha yüksek oranda saptandı (p=0.000). Laboratuvar değerlerinde; anemiye kadınlarda, hipoalbuminemiye erkeklerde anlamlı ölçüde daha yüksek oranda rastlandı. Tüberküloz ilaçlarına karşı toplam direnç erkeklerde, daha yüksek oranda bulundu (p=0.268). En sık görülen yan etki hepatotoksisite idi (p=0.843). Bir aylık tedavi sonrası radyolojik yanıt bakımından gruplar arasında anlamlı fark saptanmadı (p=0.366). Kadın ve erkek tüberkülozlu olgular arasında hastalığın prognozunu ya da tedavisini değiştirecek herhangi bir özellik saptanmamıştır. Tüberküloz kontrol programları geliştirilmesinde cinsiyet farklılıkları konusuna karşı duyarlı olunmalıdır.
COMPARISION OF THE MALE AND FEMALE CASES WITH PULMONARY TUBERCULOSIS
This study has been planned with the aim of researching the differences between male and female tuberculous cases according to bacteriological, radiological and clinical features, laboratory findings, rates of drug resistance, response to treatment and side effects of drugs. After retrospective analysis of the records of patients hospitalized in our clinic with the diagnosis of tuberculosis during a four year period, the first 100 male and 100 female cases have been included the study. While cough was the most frequent symptom in both groups, any significant difference wasn't observed among the symptoms except for sputum. The period of time for initiation of symptoms was longer in females (p=0.552). In females, the history of contact with tuberculous patient was significantly more (p=0.014), in males smoking and alcohol abuse were more (p=0.000). Among laboratory findings, anemia was more significant in females and hypoalbuminemia was more significant in males. The rate of total resistance to anti-tuberculosis agents was higher in males than in females (p=0.268). The most common side effect of treatment was hepato-toxicity and no difference was found between males and females according to the frequency of side effects (p=0.843). After a period of treatment for one month, any difference wasn't observed between the groups according to radiological response (p=0.366). Between male and female tuberculous cases, any statistically significant difference, that can alter the prognosis or treatment of tuberculosis, wasn't observed. Gender differences must be considered while developing tuberculosis control programmes.
___
- 1. TC Sa¤l›k Bakanl›¤› Verem Savafl Daire
Baflkanl›¤›. Türkiye’de Tüberkülozun Kontrolü
‹çin Baflvuru Kitab›. Ankara 2003.
- 2. World Health Organization. TB advocacy, a
practical guide. Geneva, Switzerland, World
Health Organization, 1998.
- 3. World Bank. Word Development report 1993:
Investing In Health. Oxford University Pres,
1993.
- 4. Grzybowski S, Enarson D. Tuberculosis. In:
Simmons DH, ed. Current Pulmonolgy, Chicago,
Year Book Medical Publishers, 1985; 73-96.
- 5 Connolly M, Nunn P. Women and tuberculosis.
World Health Stat Q 1996; 49: 115-20.
- 6. Sony A. El Beyers DN, Enarson DA, Chan–
Yeung M. Tuberculosis in women. In: Buist
S, Mapp CE (eds). Respiratory Diseases In
Women. ERS Monograph 25. 2003: 8; 152-
166. UK
- 7. Burton RC, Ferguson P, Gray P, Hall M, Hayes
M, Smart YC. Effects of age, gender, and
sigarette smokingon human immunoregulatory
T cell subsets: establishment of normal
ranges and comparison with patients with
colorectal cancer and multipl sclerosis. Diagn
‹mmunol 1983; 1: 216-23.
- 8. Rook Gaw, Onjyebujoh P, Standford JL.
Th1/Th2 switch and loss of CD4 cell in
chronic infection; an immuno-endocrionological
hypothesis not exclusive to HIV.
Immunol Today 1993; 14: 568-9.
- 9. Chan-Yeung M, Noertjojo K, Chan S L, Tam C
M. Sex differences in tuberculosis in Hong
Kong. Int J Tuberc Lung Dis 2002; 6: 11-18.
- 10. Cassels A, Heineman E, LeClerq S. Tuberculosis
case-finding in Eastern Nepal. Tubercle
1982; 63: 173-85.
- 11. Boeree MJ, Harries AD, Godschalk P, et al.
Gender differences in the relation to sputum
submission and smear positive pulmonary
tuberculosis in Malawi. Int J Tuberc Lung Dis
2000; 4: 882-4.
- 12. Smith I. Women and tuberculosis; gender
issues and tuberculosis control in Nepal.
Nuffield Institute For Health, 1994.
- 13. Cegielski JP, Goetz MB, Jacobsan JM, et al.
Gender differences in early suspicion on
tuberculosis in hospitalized, high risk patients
during 4 epidemic years, 1987 to 1990. Infect
Control Hosp Epidemiol 1997; 18: 237-43.
- 14. Rieder HL, Snider DE, Cauthen GM. Extrapulmonary
tuberculosis in United States. Am
Rev Respir Dis 1990; 141: 347-51.
- 15. Kalaç N, Baflay N, Mutluay N ‹. Ekstrapulmoner
tutulum gösteren tüberküloz olgular›. Tüberküloz
ve Toraks Dergisi 1999; 47: 213-5.
- 16. Tavusbay N, Aksel N, Çakan A ve ark. Ekstrapulmoner
Tüberkülozlu Olgular›m›z. Solunum
Hastal›klar› Dergisi 2000; 11: 294-8.
- 17. Matsushita Y, Ikeda N, Kurasawa T, et al. The
characteristics of clinical features of pulmonary
tuberculosis in female. Kekkaku 1996;
71: 391-8.
- 18. Lomachenkov VD, Kosheleva GI. Psychological
features of new male and female
cases of pulmonary tuberculosis and their
social adaptation. Probl Tuberc 1997; 3: 9-11.
- 19. Johansson E, Long NH, Diwan V K, Winkist
A. Attitudes to compliance with tuberculosis
treatment among women and men in Vietman.
Int J Tuberc Lung Dis 1999; 3: 862-8.
- 20. Noertjojo J, Tam CM, Chan SL, Chan-Yeung
M. Extrapulmonary tuberculosis in Hong Kong.
Am J Respir Crit Care Med 2001; 163: 99.
- 21. Van der Wef TSDG, Van der Mark TW. Patients
compliance with tuberculosis treatment in Ghana:
factors influencing adherence to therapy in a
rural service programme. Tubercle 1990; 71:
247-52.
- 22. Johansson E, Long N H, Diwan W K. Gender
and tuberculosis control. Perspectives on
health seeking behaviour among men and
women in Vietnam. Health Policy 200; 52:
33-51.
- 23. Nichter N. IlIness semantics and international
health: the weak lungs. TB complex in the
Philippines. Soc Sci Med 1994; 38: 649-63.
- 24. Tahao¤lu K. Tüberküloz tedavisi s›ras›nda
geliflen hepatotoksisitede klinik yaklafl›m.
Ankem Dergisi 1998; 12: 378-83.
- 25. Omerod LP, Skinner C, Wales C. Hepatotoxicity
of antituberculosis drugs. Thorax
1996; 51: 11-3.
- 26. Thampson NP, Caplinn ME, Hamilton MI, et al.
Antituberculosis medication and the liver:
Dangers and recomendations in management.
Eur respir J 1995; 8: 1384-8.
- 27. Steele MA, Burk RF, Des Prez RM. Toxic
hepatitis with isoniazid and rifampin. Chest
1991; 99: 465-71.
- 28. Moulding TS, Redeeker AG, Kanel GC. Twenty
isoniasid-associated deaths in one state.
Am Rev Respir Dis 1989; 140: 700-5.
- 29. Do¤an H, Aksel N, Dereli fi, Özsöz A. Tüberkülozun
yafll› ve gençlerdeki özelliklerinin
karfl›laflt›r›lmas›. Akci¤er Arflivi 2001; 3: 100-6.
- 30. Weber H, Schaaf HS, Beyers N, et al. The
clinical and radiological features of tuberculosis
in adolescents. Ann Trop Pediatr
2000; 20: 5-10.
- 31. Özkara fi, fiipit T, Berktafl B ve ark. Tüberkülozda
ilaç direncinin epidemiyolojik özellikleri.
Solunum Hastal›klar› 1995; 6: 223-32.